
Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Citalopram Action Pathway (New)
Homo sapiens
Drug Action Pathway
Citalopram is a selective serotonin reuptake inhibitor used to manage depression, anxiety. Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioral changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy. Citalopram binds selectively to the sodium dependent serotonin transporter and blocks the recycling of serotonin from the synapse. As serotonin accumulates it restores the serotonergic function of the 5-hydroxytryptamine 1A receptor leading to decreased anxiety and depressive moods. Citalopram is usually taken orally. The onset of action for depression is about 2 to 4 weeks. However, the full response may take up 8 to 12 weeks.
References
Citalopram Pathway (New) References
Yohn C. N, Gergues M. M, Samuels B. A. The role of 5-HT receptors in depression. Mol Brain 10: 28, 2017.
Wishart, D., Knox, C., Guo, A., Shrivastava, S., Hassanali, M., Stothard, P., . . . Woolsey, J. (2005, June). Citalopram. Retrieved May 25, 2021, from https://go.drugbank.com/drugs/DB00215
Sharbaf Shoar N, Fariba K, Padhy RK: Citalopram
Pubmed: 29489221
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings